Lisata Therapeutics Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Lisata Therapeutics Stock Summary

Lisata Therapeutics competes with Lixte Biotechnology, Imunon, Rezolute, XOMA, and Protagenic Therapeutics. Lisata Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing cellular therapies to reverse disease andor promote the regeneration of damaged tissue. Lisata Therapeutics, Inc. was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey. Lisata Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 27 people.

Lisata Therapeutics Key Financial Ratios

Lisata Therapeutics Key Balance Sheet Accounts

Lisata Therapeutics Key Income Statement Accounts

Lisata Therapeutics Key Cash Accounts

Lisata Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Lisata Therapeutics's current stock value. Our valuation model uses many indicators to compare Lisata Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Lisata Therapeutics competition to find correlations between indicators driving Lisata Therapeutics's intrinsic value. More Info.Lisata Therapeutics is rated fourth overall in return on equity category among its peers. It is rated fifth overall in return on asset category among its peers . At present, Lisata Therapeutics' Return On Equity is projected to increase slightly based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Lisata Therapeutics' earnings, one of the primary drivers of an investment's value.

Lisata Therapeutics Systematic Risk

Today, most investors in Lisata Therapeutics Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Lisata Therapeutics' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Lisata Therapeutics growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Lisata Therapeutics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Lisata Therapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Lisata Therapeutics based on widely used predictive technical indicators. In general, we focus on analyzing Lisata Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Lisata Therapeutics's daily price indicators and compare them against related drivers.

When running Lisata Therapeutics' price analysis, check to measure Lisata Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lisata Therapeutics is operating at the current time. Most of Lisata Therapeutics' value examination focuses on studying past and present price action to predict the probability of Lisata Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lisata Therapeutics' price. Additionally, you may evaluate how the addition of Lisata Therapeutics to your portfolios can decrease your overall portfolio volatility.